Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Odevixibat in Children With Biliary Atresia Post-Kasai Hepatoportoenterostomy
NCT04336722Phase 3Completed
- Sponsor
- Ipsen
- Start
- Jul 2020
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 19
01
Overview
A Phase 3 trial of odevixibat in biliary atresia, sponsored by Ipsen. Started Jul 2020; status: completed.
02
Drugs
odevixibat
03
Conditions
biliary atresia
Beyond the preview
Go deeper on NCT04336722.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04336722.